Novoray Corporation

SHSE:688300 Voorraadrapport

Marktkapitalisatie: CN¥9.9b

Novoray Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Novoray heeft een totaal eigen vermogen van CN¥1.4B en een totale schuld van CN¥95.5M, wat de schuld-eigenvermogensverhouding op 6.6% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥1.9B en CN¥477.5M. De EBIT Novoray is CN¥241.9M waardoor de rentedekking -16.4 is. Het heeft contanten en kortetermijnbeleggingen van CN¥420.8M.

Belangrijke informatie

6.6%

Verhouding schuld/eigen vermogen

CN¥95.54m

Schuld

Rente dekkingsratio-16.4x
ContantCN¥420.81m
AandelenCN¥1.44b
Totaal verplichtingenCN¥477.46m
Totaal activaCN¥1.92b

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Recent updates

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

Oct 18
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26
What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Jul 29
Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Jul 13
What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Jun 19
Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27
When Should You Buy Novoray Corporation (SHSE:688300)?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥1.0B ) 688300 } overtreffen de korte termijn passiva ( CN¥316.5M ).

Langlopende schulden: De kortetermijnactiva 688300 ( CN¥1.0B ) overtreffen de langetermijnschulden ( CN¥161.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688300 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 688300 is de afgelopen 5 jaar gedaald van 7.8% naar 6.6%.

Schuldendekking: De schuld van 688300 wordt goed gedekt door de operationele kasstroom ( 259.6% ).

Rentedekking: 688300 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y